Spectrum of Post-COVID-19 Complications in Pediatric Patients: A Case Series
Abstract
The COVID-19 epidemic posed significant challenges to global health systems, highlighting the need for research into the virus’s complex pathology and the development of targeted interventions. Despite existing management options, post-COVID complications in paediatric patients with underlying haematological and immunological vulnerabilities present a pressing concern. This case series presents four paediatric patients with complex post-COVID complications and underlying disorders, including chronic myeloid leukaemia with disseminated intravascular coagulation, Evans syndrome with coeliac disease, Guillain-Barré syndrome, and multisystem inflammatory syndrome in children (MIS-C). These cases underscore the importance of early recognition and multidisciplinary management in achieving optimal outcomes.
DOI: https://doi.org/10.24321/0019.5138.202668
How to cite this article:
Singh S, Alam S, Singh N, Anil V K, Elwadhi A, Rai S, Chopra K K. Spectrum of Post-Covid-19
Complications in Pediatric Patients: A Case Series. J Commun Dis. 2026;58(3):218-225.
References
Rotulo GA, Palma P. Understanding COVID-19 in children: immune determinants and post-infection conditions. Pediatric research. 2023 Aug;94(2):434-42. [Google Scholar]
Kostos L, Burbury K, Srivastava G, Prince HM. Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report. Platelets. 2015 Nov 17;26(8):809-11. [Google Scholar]
Zheng WL, Zhang GS, Shen JK, Pei MF, Peng HL, Xu M. Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy. Thrombosis research. 2011 Aug 1;128(2):202- 3. [Google Scholar]
Kruse-Jarres R, Singleton TC, Leissinger CA. Identification and basic management of bleeding disorders in adults. The Journal of the American Board of Family Medicine. 2014 Jul;27(4):549-64. [Google Scholar]
Soehalino S, Setyoningrum RA, Cahyadi A. Coagulopathy and clinical outcomes of pediatric cancer patients with COVID-19 infection in Surabaya. Journal of Medicinal and Pharmaceutical Chemistry Research. 2025 Jun;7(6):1119-29. [Google Scholar]
Abudouleh EA, Alhamlan F, Al-Qahtani AA, Bohol MF, Al Hazzani A, Khorfan K, Alkaff M, Owaidah T, Al-Qahtani AA. Changes in the fibrinolytic system of patients infected with severe acute respiratory syndrome coronavirus 2. Journal of Clinical Medicine. 2023 Aug 10;12(16):5223. [Google Scholar]
Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2- induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine & Growth Factor Reviews. 2022 Feb 1;63:58-68. [Google Scholar]
Saes JL, Schols SE, Van Heerde WL, Nijziel MR. Hemorrhagic disorders of fibrinolysis: a clinical review. Journal of Thrombosis and Haemostasis. 2018 Aug;16(8):1498-509. [Google Scholar]
Tarar ZI, Zafar MU, Farooq U, Basar O, Tahan V, Daglilar E. The progression of celiac disease, diagnostic modalities, and treatment options. Journal of investigative medicine high impact case reports. 2021 Oct;9:23247096211053702. [Google Scholar]
Cooper BT, Holmes GK, Cooke WT. Coeliac disease and immunological disorders. British medical journal. 1978 Mar 4;1(6112):537-9. [Google Scholar]
Copyright (c) 2026 Journal of Communicable Diseases (E-ISSN: 2581-351X & P-ISSN: 0019-5138)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
